PHOTOSOFTTM SHOWS ACTIVITY AGAINST ZIKA VIRUS IN PRELIMINARY ASSAYS
Highlights: - PhotosoftTM compounds demonstrated ≥99% inhibition against Zika virus in cell-based assays following the application of light - Zika virus is found in 86 countries and has been linked to birth defects and other neurological complications - The Zika virus market is estimated to be worth ~US$17 billion in 20221 with no treatments for the disease currently available2 - Several PhotosoftTM compounds had over 100 times the activity of Monensin (selected control) in vitro
